Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-042500
Date:2020-07-14
Issuer: POSEIDA THERAPEUTICS, INC. (PSTX)
Original Submission Date:

Reporting Person:

MURPHY SEAN
C/O POSEIDA THERAPEUTICS, INC.
9390 TOWNE CENTRE DRIVE, SUITE 200 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-07-14 C 7,013,918 a $0.00 7,013,918 indirect
COMMON STOCK 2020-07-14 C 1,168,985 a $0.00 8,182,903 indirect
COMMON STOCK 2020-07-14 C 690,124 a $0.00 8,873,027 indirect
COMMON STOCK 2020-07-14 C 315,098 a $0.00 9,188,125 indirect
COMMON STOCK 2020-07-14 P 10,000 a $16.00 10,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
SERIES A PREFERRED STOCK 0.0 2020-07-14 deemed execution date C 8,746,356 (d) common stock 7,013,918 $0.00 0 indirect see footnote
SERIES A-1 PREFERRED STOCK 0.0 2020-07-14 deemed execution date C 1,457,725 (d) common stock 1,168,985 $0.00 0 indirect see footnote
SERIES B PREFERRED STOCK 0.0 2020-07-14 deemed execution date C 860,585 (d) common stock 690,124 $0.00 0 indirect see footnote
SERIES C PREFERRED STOCK 0.0 2020-07-14 deemed execution date C 392,927 (d) common stock 315,098 $0.00 0 indirect see footnote
Footnotes
IDfootnote
f1 each share of the issuer's series a preferred stock, series a-1 preferred stock, series b preferred stock and series c preferred stock (collectively, the "preferred stock") automatically converted into 0.8019246 shares of the issuer's common stock upon the closing of the issuer's initial public offering. the preferred stock had no expiration date.
f2 represents shares of common stock issuable upon conversion of preferred stock held by malin holdings, a wholly owned subsidiary of malin corporation plc ("malin"), and may be deemed to be beneficially owned by malin. malin may be deemed to share voting and investment power over securities held by malin holdings. mr. murphy currently serves as a member of the leadership team at malin. the reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of section 16 or for any other purpose.
WhaleWisdom Logo

Elevate your investments